FDA Compliance Intelligence and GxP Advisory Built for
Real-World Life Sciences Operations
If you are responsible for FDA compliance, quality systems, or regulatory risk inside a pharmaceutical, medical device, biologics, or dietary supplement organization, this page exists to solve one problem clearly and completely. How to stay inspection-ready, avoid preventable FDA citations, and make confident decisions using current compliance intelligence instead of outdated guidance or guesswork.
ComplyFDA delivers industry-validated GxP assessments, real-time compliance intelligence, and compliance analytics that reflect how the FDA actually inspects today. Not theory. Not templates pulled from a decade ago. This work is grounded in active FDA enforcement trends, Form 483 observations, Warning Letters, and the same risk signals inspectors are trained to look for when they walk onto your site.
Our clients operate in the same pressure cooker you do. Tight timelines. Limited internal resources.
Cross-functional friction between Quality, Operations, and Executive leadership. Whether you are preparing for a pre-approval inspection, responding to an inspection outcome, or trying to prevent the next one from happening, the goal is the same. Clarity, control, and defensible compliance decisions.
This is not generic consulting. Our services are built for organizations operating in highly regulated U.S. life sciences corridors like New Jersey, Pennsylvania, Massachusetts, North Carolina, California, Texas, and expanding manufacturing hubs across the Midwest and Southeast. Teams that live with FDA scrutiny year-round. Teams that cannot afford surprises.
Everything on this page is designed to answer the questions compliance leaders actually ask before an inspection happens. Where are we exposed. What will FDA cite first. What does current enforcement data say about our risk profile. What should we fix now versus later. And how do we prove control when an investigator asks for evidence.
If your role touches FDA compliance, quality oversight, regulatory intelligence, or executive risk accountability, you are in the right place. This page is your starting point, and for many teams, it becomes the last place they need to search.
FDA Compliance Intelligence and Quality System Services
Industry-Validated Best Practices for GxP Systems and Inspection Readiness
FDA inspections consistently surface design control and quality system weaknesses that organizations assume are under control. Our GxP systems assessments are built to identify these risks early by evaluating how design control, quality system execution, and inspection readiness perform in real operations, not just in documented procedures.
Using industry-validated best practices and a structured assessment methodology, we review design planning, risk-based inputs, verification and validation alignment, design changes, and management oversight. Assessments are informed by current FDA enforcement activity, allowing teams to focus on what inspectors actually examine and cite.
This service is designed for organizations preparing for FDA inspections, scaling development or manufacturing, or seeking a clear, defensible understanding of GxP system maturity before regulatory pressure forces the issue.
Quarterly FDA Compliance Intelligence and Enforcement Trend Reports
Staying ahead of FDA enforcement requires more than reacting to inspection outcomes after they happen. Our quarterly compliance intelligence reports track active FDA compliance activity across pharmaceuticals, medical devices, biologics, and dietary supplements, with a rolling 24-month view of enforcement trends.
Each report consolidates Form 483 observations, Warning Letters, and relevant compliance citations into clear, easy-to-interpret visualizations. Active links to source regulations and enforcement actions eliminate time-consuming searches across FDA databases and allow teams to quickly validate context and impact.
These reports are built for quality, regulatory, and executive teams that need timely visibility into where FDA attention is increasing, what issues are being cited most often, and how enforcement patterns are shifting before they show up at their own facilities.
Regulatory Activity Monitoring and Compliance Dashboard Reporting
Understanding FDA enforcement requires more than static reports. Our FDA compliance activity monitoring and dashboard reporting provide ongoing visibility into FDA citations, inspection findings, and compliance trends across pharmaceuticals, medical devices, biologics, and dietary supplements.
Standard and custom dashboards translate citation-level data into clear visual formats using ComplyFDA’s proprietary regulatory activity database. Teams can quickly identify patterns by regulation, subpart, product type, or time period, allowing faster risk assessment and better-informed compliance decisions.
This service is designed for organizations that need continuous awareness of regulatory signals, executive-ready reporting, and the ability to drill into enforcement data without relying on manual research or fragmented FDA sources.
Baseline Quality System Risk Assessment
When organizations need a clear starting point, our baseline quality system assessment provides a focused, objective view of FDA and ISO compliance risk. This assessment is designed to quickly establish where quality systems are strong, where gaps exist, and which issues require immediate attention.
Using industry-validated best practices, we evaluate core quality system elements and provide an objective score supported by practical, prioritized improvement recommendations. The result is clarity without disruption, allowing teams to plan next steps with confidence and avoid preventable regulatory exposure.
This service is well suited for organizations preparing for inspections, standardizing quality systems across sites, onboarding new leadership, integrating operations, or seeking an independent assessment before regulatory risk escalates across regulated operations.
Built for FDA Reality, Not Theoretical Compliance
Every service on this page is designed around how FDA inspections actually unfold. Real enforcement data. Real inspection behavior. Real risk signals that quality and regulatory teams face every day. Whether you need a focused baseline, ongoing compliance intelligence, or a deeper assessment of GxP system performance, these services are built to reduce uncertainty and replace assumptions with clarity.
This hub is your starting point. Each section connects to a deeper, purpose-built solution for organizations that want to stay inspection ready, informed, and in control before regulatory pressure escalates.
